hutchison biofilm medical solutions limited
hutchison biofilm medical solutions limited Company Information
Group Structure
View All
Industry
Registered Address
vistra corporate services centre, marlborough & queen streets, nassau, new providence
Website
-hutchison biofilm medical solutions limited Estimated Valuation
Pomanda estimates the enterprise value of HUTCHISON BIOFILM MEDICAL SOLUTIONS LIMITED at £0 based on a Turnover of £0 and 0x industry multiple (adjusted for size and gross margin).
hutchison biofilm medical solutions limited Estimated Valuation
Pomanda estimates the enterprise value of HUTCHISON BIOFILM MEDICAL SOLUTIONS LIMITED at £0 based on an EBITDA of £-21.9k and a 0x industry multiple (adjusted for size and gross margin).
hutchison biofilm medical solutions limited Estimated Valuation
Pomanda estimates the enterprise value of HUTCHISON BIOFILM MEDICAL SOLUTIONS LIMITED at £0 based on Net Assets of £-80.2k and 0x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Hutchison Biofilm Medical Solutions Limited Overview
Hutchison Biofilm Medical Solutions Limited is a converted/closed company that was located in nassau. Founded in December 2015, it's largest shareholder was unknown. The last turnover for Hutchison Biofilm Medical Solutions Limited was estimated at £0.
Upgrade for unlimited company reports & a free credit check
Hutchison Biofilm Medical Solutions Limited Health Check
There is insufficient data available to calculate a health check for Hutchison Biofilm Medical Solutions Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Hutchison Biofilm Medical Solutions Limited
- - Industry AVG
HUTCHISON BIOFILM MEDICAL SOLUTIONS LIMITED financials
Hutchison Biofilm Medical Solutions Limited's latest turnover from December 2022 is 0 and the company has net assets of -£80.2 thousand. According to their latest financial statements, we estimate that Hutchison Biofilm Medical Solutions Limited has no employees and maintains cash reserves of £13.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | -21,010 | -35,572 | -96,799 | -596,328 | -949,146 | -1,795,391 | -2,501,502 | -1,818,778 | -548,851 |
| Tax | |||||||||
| Profit After Tax | -21,010 | -35,572 | -96,799 | -596,328 | -949,146 | -1,795,391 | -2,501,502 | -1,818,778 | -548,851 |
| Dividends Paid | |||||||||
| Retained Profit | -21,010 | -35,572 | -96,799 | -596,328 | -949,146 | -1,795,391 | -2,501,502 | -1,818,778 | -548,851 |
| Employee Costs | |||||||||
| Number Of Employees | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||
| Intangible Assets | |||||||||
| Investments & Other | |||||||||
| Debtors (Due After 1 year) | |||||||||
| Total Fixed Assets | |||||||||
| Stock & work in progress | |||||||||
| Trade Debtors | |||||||||
| Group Debtors | 150,972 | 186,799 | 32,237 | ||||||
| Misc Debtors | 3 | 4 | 3 | 3 | 3 | 3 | 27,985 | 3 | 268,513 |
| Cash | 13,229 | 34,902 | 55,325 | 232,329 | 685,740 | 272,463 | 1,147,501 | ||
| misc current assets | 325 | 10,593 | 5,115 | 147 | |||||
| total current assets | 13,234 | 37,696 | 55,654 | 242,927 | 841,832 | 459,414 | 1,175,486 | 4 | 300,751 |
| total assets | 13,234 | 37,696 | 55,654 | 242,927 | 841,832 | 459,414 | 1,175,486 | 4 | 300,751 |
| Bank overdraft | |||||||||
| Bank loan | |||||||||
| Trade Creditors | |||||||||
| Group/Directors Accounts | 1 | 1 | 1 | 1 | 1 | 1 | |||
| other short term finances | |||||||||
| hp & lease commitments | |||||||||
| other current liabilities | 93,422 | 99,749 | 79,382 | 169,855 | 152,255 | 432,411 | 973,241 | 505,851 | 1,466,083 |
| total current liabilities | 93,423 | 99,750 | 79,382 | 169,856 | 152,256 | 432,412 | 973,242 | 505,852 | 1,466,084 |
| loans | |||||||||
| hp & lease commitments | |||||||||
| Accruals and Deferred Income | |||||||||
| other liabilities | |||||||||
| provisions | |||||||||
| total long term liabilities | |||||||||
| total liabilities | 93,423 | 99,750 | 79,382 | 169,856 | 152,256 | 432,412 | 973,242 | 505,852 | 1,466,084 |
| net assets | -80,190 | -62,054 | -23,728 | 73,071 | 689,576 | 27,002 | 202,245 | -505,848 | -1,165,333 |
| total shareholders funds | -80,190 | -62,054 | -23,728 | 73,071 | 689,576 | 27,002 | 202,245 | -505,848 | -1,165,333 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | |||||||||
| Amortisation | |||||||||
| Tax | |||||||||
| Stock | |||||||||
| Debtors | -1 | 1 | -150,973 | -35,827 | 158,818 | 27,982 | -300,747 | 300,750 | |
| Creditors | |||||||||
| Accruals and Deferred Income | -6,327 | 20,367 | -90,473 | 17,600 | -280,156 | -540,830 | 467,390 | -960,232 | 1,466,083 |
| Deferred Taxes & Provisions | |||||||||
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | |||||||||
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | |||||||||
| Group/Directors Accounts | 1 | -1 | 1 | ||||||
| Other Short Term Loans | |||||||||
| Long term loans | |||||||||
| Hire Purchase and Lease Commitments | |||||||||
| other long term liabilities | |||||||||
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | 2,874 | -2,754 | -20,177 | 1,611,720 | 1,620,148 | 3,209,596 | 2,478,262 | -616,481 | |
| cash and cash equivalents | |||||||||
| cash | -21,673 | -20,423 | -177,004 | -453,411 | 413,277 | -875,038 | 1,147,501 | ||
| overdraft | |||||||||
| change in cash | -21,673 | -20,423 | -177,004 | -453,411 | 413,277 | -875,038 | 1,147,501 |
hutchison biofilm medical solutions limited Credit Report and Business Information
Hutchison Biofilm Medical Solutions Limited Competitor Analysis
Perform a competitor analysis for hutchison biofilm medical solutions limited by selecting its closest rivals, whether from the industry sector, other established companies, companies in Region Area area or any other competitors across 12 key performance metrics.
hutchison biofilm medical solutions limited Ownership
HUTCHISON BIOFILM MEDICAL SOLUTIONS LIMITED group structure
Hutchison Biofilm Medical Solutions Limited has no subsidiary companies.
Ultimate parent company
HUTCHISON BIOFILM MEDICAL SOLUTIONS LIMITED
FC033062
hutchison biofilm medical solutions limited directors
Hutchison Biofilm Medical Solutions Limited currently has 4 directors. The longest serving directors include Dr Dan Eldar (Jan 2016) and Mr Kong Chow (Oct 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Dan Eldar | Israel | 71 years | Jan 2016 | - | Director |
| Mr Kong Chow | United Kingdom | 51 years | Oct 2018 | - | Director |
| Dr Edmond Ho | United Kingdom | 65 years | Oct 2018 | - | Director |
| Mr Chi Leung | United Kingdom | 57 years | Oct 2018 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
-21.9k
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-80.2k
+0.29%
total assets
13.2k
-0.65%
cash
13.2k
-0.62%
net assets
Total assets minus all liabilities
Similar Companies
hutchison biofilm medical solutions limited company details
company number
FC033062
Type
Other
industry
incorporation date
December 2015
age
10
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2022
previous names
N/A
accountant
-
auditor
-
address
vistra corporate services centre, marlborough & queen streets, nassau, new providence
Bank
-
Legal Advisor
-
hutchison biofilm medical solutions limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to hutchison biofilm medical solutions limited.
hutchison biofilm medical solutions limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HUTCHISON BIOFILM MEDICAL SOLUTIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
hutchison biofilm medical solutions limited Companies House Filings - See Documents
| date | description | view/download |
|---|
